Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.
about
Epidemiology and risk factors for invasive candidiasisThe Peptide-binding Cavity Is Essential for Als3-mediated Adhesion of Candida albicans to Human CellsRapid identification of medically important Candida isolates using high resolution melting analysisEpidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in ItalyNational surveillance of fungemia in Denmark (2004 to 2009)Epidemiology of invasive candidiasis: a persistent public health problemVisual analysis of DNA microarray data for accurate molecular identification of non-albicans Candida isolates from patients with candidemia episodes.Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links.Uniform distribution of three Candida albicans microsatellite markers in two French ICU populations supports a lack of nosocomial cross-contamination.Rapid species diagnosis for invasive candidiasis using mass spectrometryEpidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in ShanghaiCandidemia in the elderly: What does it change?Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, IndiaImproved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization Biotyper system.Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients.One year prospective survey of Candida bloodstream infections in Scotland.Rapid identification of Candida species and other clinically important yeast species by flow cytometry.Microsatellite marker analysis as a typing system for Candida glabrata.Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.Candidiasis caused by Candida kefyr in a neonate: case report.Canadian clinical practice guidelines for invasive candidiasis in adults.Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory.Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in SpainWeekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasisRelationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patientsEconomic considerations of antifungal prophylaxis in patients undergoing surgical proceduresEpidemiology of candidemia in Latin America: a laboratory-based survey.Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phaseRapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2.The synthetic amphipathic peptidomimetic LTX109 is a potent fungicide that disturbs plasma membrane integrity in a sphingolipid dependent mannerSurveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.Invasive candidiasis in non-hematological patients.Correspondence (letter to the editor): Non-albicans Candida species.
P2860
Q27024911-2787FCAC-A47E-4CF5-8D11-B0A8572F5140Q27683658-52CA91A3-C8DC-46BA-B84F-A1C70944BCC1Q28543415-7D6BA7A1-5B17-4459-8FAF-C03CDA05E490Q28740362-A3FC5F69-06E2-4A83-9929-A386B257C6C4Q28743556-936C1AC9-7DF7-4878-8E36-854F216A69C4Q29616758-684AAEEB-A467-481F-90B6-D326E03E1779Q30391760-653CBB23-39CF-460B-B969-2A2B8E2FCCA8Q30447051-A2F61E9D-2136-4A48-93E2-A61766270103Q31152900-797BC28A-1D5E-405C-89E5-AAAE85C36164Q33241991-3237EB1E-0DF3-48A5-9582-867780A6E0F0Q33263440-3A97D1E6-0951-491E-8C2C-FD924AFC4442Q33527403-AEFC07A0-5E8D-425B-A371-492A92FD9AEAQ33661367-E5AD5865-A8F4-4D22-84B6-C01C1868EE31Q33663448-4ECB44EC-AE6A-4D2C-9CDE-B521F78EA192Q33816237-6DA1ABDF-2B6B-460D-A341-382F0B6A6FDDQ33851338-53656531-72EF-407E-8290-21E4FD9358F7Q33890222-BB37F18D-89E7-4946-B595-2444FE61A1D6Q33903375-4868A18F-405E-4FC7-B544-4BBCA8C18E13Q33910250-21FA1251-23F8-4EA6-8597-1214538E83A1Q34042068-EBBFE074-2FA7-48BE-9C55-9F31CE76C554Q34042191-756CFD9E-FAF0-4464-87EB-2B77988BAD92Q34042232-45A4C999-6CA2-4E5D-958C-C1D4A04354A8Q34051921-A43AE384-D5DE-4980-907C-F0C6A4BE85EBQ34165039-EA8092D8-C3CF-4A2B-BC42-6E1AA8F39266Q34198136-2F053F52-B972-4D4D-8BD1-3D0798363226Q34237335-16B04315-42AB-4594-9594-E1FD659E2756Q34414698-BA953C48-5236-49A6-AA98-E8AD41A4A4C3Q34489579-BB2EBA48-FF65-4F4E-9D9D-B1638915176AQ34517297-7D5ABB56-616A-41C4-AA00-5D04487D1DD6Q34528342-AC99F33E-377C-4F3F-A005-08F4C221EAC7Q34529026-27BBAB13-CEEA-4BEA-A0AE-DD3857C77821Q34574154-2E84661B-FA54-4495-A8A3-218544DED102Q34635088-86F7308D-59F6-4FB6-8B25-1B8A3A8D39A9Q34643153-17E7C077-65E9-4CB7-BB67-2E5C23292408Q34663458-C83F4474-1BBC-411E-9B95-514283E2B78EQ34854161-7F7ED84C-8184-4247-9FFD-6AE67208D21AQ34856747-737E4D0F-F610-415D-8623-21D747254F94Q34932922-A36E0D05-D6B7-486D-B59B-748520BDE481Q35010671-ABDD37C9-FCE3-411E-BC7C-F7D0ADC915AEQ35013257-62BF0556-F928-4176-A480-B2697CE80506
P2860
Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Epidemiology of candidaemia in ...... ital-based surveillance study.
@en
type
label
Epidemiology of candidaemia in ...... ital-based surveillance study.
@en
prefLabel
Epidemiology of candidaemia in ...... ital-based surveillance study.
@en
P2093
P1476
Epidemiology of candidaemia in ...... pital-based surveillance study
@en
P2093
C C Kibbler
ECMM Working Group on Candidaemia
H Bernhardt
K Zimmermann
L Klingspor
P2888
P304
P356
10.1007/S10096-004-1103-Y
P577
2004-03-17T00:00:00Z
P6179
1051069641